髋关节发育不良损害股骨髋臼撞击症手术的疗效
本研究比较了73例髋关节发育不良患者与550例无发育不良患者接受股骨髋臼骨成形术(FAO)的结局,发育不良组改良Harris髋关节评分和SF-36评分均显著低于对照组,治疗失败率更高(28.8% vs 2.5%)。作者认为,尽管FAO和盂唇修复对发育不良患者可能是一种选择,但结局不如无发育不良的股骨髋臼撞击症患者,应限于轻度和临界发育不良者。
要点
- 发育不良组平均改良Harris髋关节评分为75.1,低于无发育不良组的83.4。
- 发育不良组平均SF-36评分为74.3,低于无发育不良组的85.6。
- 发育不良组治疗失败率为28.8%,高于无发育不良组的2.5%。
核心结论
- 尽管盂唇修复和FAO对髋关节发育不良患者可能是一种选择,但该人群的结局似乎不如无发育不良证据的股骨髋臼撞击症患者。
- 作者认为,盂唇修复和骨成形术应限于轻度和临界发育不良的患者。
研究设计与样本
- 研究纳入2007年至2015年间接受FAO的73例髋关节发育不良患者(38例男性,35例女性),并与同一术者行FAO的550例无发育不良患者进行比较。
- 比较两组至少2年的临床、功能(改良Harris髋关节评分和SF-36健康调查)和影像学结局。
- 术前和术后评估α角、Tonnis分级、关节间隙和软骨损伤情况并进行比较。
- 将转为全髋关节置换术或翻修FAO视为治疗失败。
主要发现
- 发育不良组平均年龄为30.7±11.8岁,无发育不良组为34.5±11.2岁。
- 发育不良组平均随访4.3年,无发育不良组平均随访4.1年。
- 发育不良组平均改良Harris髋关节评分为75.1、SF-36评分为74.3,均显著低于无发育不良组的83.4和85.6。
- 发育不良组治疗失败率为28.8%,高于无发育不良组的2.5%。
关键数值与推荐
- 发育不良组平均改良Harris髋关节评分为75.1,无发育不良组为83.4。
- 发育不良组平均SF-36评分为74.3,无发育不良组为85.6。
- 发育不良组治疗失败率为28.8%,无发育不良组为2.5%。
临床怎么用
- 作者认为,盂唇修复和FAO对髋关节发育不良患者可能是一种选择,但结局似乎不如无发育不良的股骨髋臼撞击症患者。
- 作者认为,盂唇修复和骨成形术应限于轻度和临界发育不良的患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal treatment for patients with symptomatic hip dysplasia presenting with labral tear is unknown. Although femoroacetabular osteoplasty (FAO) has excellent outcome for most femoroacetabular impingement patients, the presence of concomitant hip dysplasia has been implicated as an adverse prognostic factor. This study evaluated the outcome of FAO in a group of dysplastic hips and compared the outcome to a cohort of patients without dysplasia. METHODS: Seventy-three patients (38 males, 35 females) with hip dysplasia who underwent FAO between 2007 and 2015 were identified. The minimum 2-year clinical, functional (modified Harris Hip Score and Short-Form 36 Health Survey), and radiological outcome was compared with 550 patients without dysplasia who underwent FAO by the same surgeon. The preoperative and postoperative alpha angle, Tonnis grade, joint space, and presence of chondral lesion were determined and compared. Conversion to total hip arthroplasty or revision FAO was considered as treatment failure. RESULTS: The mean age in the dysplasia cohort was 30.7 ± 11.8 years compared to 34.5 ± 11.2 in the nondysplastic group. The mean follow-up was 4.3 years for dysplasia cohort and 4.1 for the nondysplastic group. The mean modified Harris Hip Score and Short-Form 36 Health Survey6 was significantly lower in the dysplastic group at 75.1 and 74.3 compared to 83.4 and 85.6 for the comparison group. There was a higher percentage of failure at 28.8% among dysplasia patients compared to 2.5% in the nondysplastic group. CONCLUSION: Although labral repair and FAO may be an option for patients with hip dysplasia, the outcome in this population appears to be less optimal compared to femoroacetabular impingement patients with no evidence of dysplasia. Labral repair and osteoplasty should be limited to those with mild and borderline dysplasia.
引用
- Vahedi H, Aalirezaie A, Rolo G, et al. Hip Dysplasia Compromises the Outcome of Femoroacetabular Impingement Surgery. J Arthroplasty. 2019. PMID: 30755376. doi:10.1016/j.arth.2019.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。